Clinical Report: Impact of Helminth Infection on Th17 Cell Plasticity
Overview
Helminth infection alters Th17 cell plasticity, inhibiting pathogenic Th1-like differentiation and promoting regulatory Tr1/Treg-like functions. This shift in Th17 behavior may provide insights into therapeutic strategies for autoimmune and inflammatory diseases.
Background
The rise of autoimmune and inflammatory diseases in industrialized nations is linked to reduced exposure to helminths, which have immunomodulatory effects. Th17 cells, crucial in mediating inflammation, exhibit plasticity that can lead to either pathogenic or regulatory functions. Understanding how helminths influence Th17 cell behavior is vital for developing new treatment approaches for immune-mediated diseases.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
Helminth infection suppresses the development of pathogenic Th1-like Th17 cells.
Exposure to Heligmosomoides polygyrus bakeri promotes the differentiation of Th17 cells into Tr1/Treg-like cells.
Helminth-infected Th17 lineage cells exhibit enhanced regulatory functions, including the suppression of T cell proliferation.
Helminth exposure reduces the frequency of Th17 cells in the mesenteric lymph node population.
Th17 lineage cells from infected mice can inhibit T cell-transfer colitis.
Clinical Implications
The findings suggest that helminth infections may offer a therapeutic avenue for modulating Th17 responses in autoimmune diseases. Clinicians should consider the potential benefits of helminth-derived immunomodulators in managing inflammatory conditions.
Conclusion
Helminth infections significantly influence Th17 cell plasticity, shifting their function towards a more regulatory profile, which may have important implications for treating autoimmune and inflammatory diseases.
